Author： Bos J.M. Postma Maarten J. Annemans Lieven
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.23, Iss.7, 2005-01, pp. : 639-649
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
By Birks Stuart
PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. :
Access to resources
Recommend
The Need for Pharmacoeconomic Evaluations in the NHS
By Griffin J.P.
PharmacoEconomics, Vol. 14, Iss. 3, 1998-09 ,pp. :
Budget impacts and pharmacoeconomic evaluations
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. :
Accounting for Noncompliance in Pharmacoeconomic Evaluations
By Hughes D.A. Bagust A. Haycox A. Walley T.
PharmacoEconomics, Vol. 19, Iss. 12, 2001-01 ,pp. :
Reporting Pharmacoeconomic Evaluations
By Carswell C.I. Paladino J.A.
PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. :